Page 103 - HIV/AIDS Guidelines

49. Baker JV, Peng G, Rapkin J, et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV
infection. AIDS. 2008;22(7):841-848.
50. Monforte A, Abrams D, Pradier C, et al. HIV-induced immunodeficiency and mortality from AIDS-defining and non-
AIDS-defining malignancies. AIDS. 2008;22(16):2143-2153.
51. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency
virus: the D:A:D study. Arch Intern Med. 2006;166(15):1632-1641.
52. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med.
2006;355(22):2283-2296.
53. Lichtenstein KA, Armon C, Buchacz K, et al. Low CD4+ T cell count is a risk factor for cardiovascular disease events in
the HIV outpatient study. Clin Infect Dis. 2010;51(4):435-447.
54. Huttner AC, Kaufmann GR, Battegay M, et al. Treatment initiation with zidovudine-containing potent antiretroviral
therapy impairs CD4 cell count recovery but not clinical efficacy. AIDS. 2007;21(8):939-946.
55. Barrios A, Rendon A, Negredo E, et al. Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus
suppression taking tenofovir and didanosine. AIDS. 2005;19(6):569-575.
56. Lacombe K, Pacanowski J, Meynard JL, et al. Risk factors for CD4 lymphopenia in patients treated with a
tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen. AIDS. 2005;19(10):1107-1108.
57. Negredo E, Bonjoch A, Paredes R, et al. Compromised immunologic recovery in treatment-experienced patients with
HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies. Clin Infect Dis.
2005;41(6):901-905.
58. Hammer S, Bassett R, Fischl MA, et al. Randomized, placebo-controlled trial of abacavir intensification in HIV-1-infect
adults with plasma HIV RNA < 500 copies/mL. Paper presented at: 11th Conference on Retroviruses and Opportunistic
Infections; February 8-11, 2004; San Francisco, CA. Abstract 56.

59. Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med.
2009;361(16):1548-1559.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents H-10

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.